{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:50Z","timestamp":1793927150533,"version":"4.8.0"},"reference-count":16,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100002679","name":"Adnan Menderes Universitesi","doi-asserted-by":"crossref","award":["TPF-19029"],"award-info":[{"award-number":["TPF-19029"]}],"id":[{"id":"10.13039\/501100002679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Metabolic Syndrome and Related Disorders"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) is a growing public health problem characterized by clustering of cardiometabolic risk factors and a chronic low-grade inflammatory state. Biomarkers such as Fetuin-A, YKL-40, and high-sensitivity C-reactive protein (hsCRP) have been implicated in insulin resistance, obesity, and atherosclerosis. Identifying accessible and cost-effective biomarkers that reflect the presence and severity of MetS may provide clinically relevant insight into metabolic burden. Therefore, this study aimed to evaluate whether inflammatory biomarkers are associated with the presence and dynamic severity of MetS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Forty-seven patients diagnosed with MetS according to National Cholesterol Education Program Adult Treatment Panel III criteria (\u22653 components) and 23 healthy controls were included. Serum hsCRP, Fetuin-A, and YKL-40 levels were measured at baseline and after a 3-month follow-up. No pharmacological treatment was initiated; participants received standardized lifestyle modification advice. Associations between biomarker levels and MetS severity scores (range 3\u20135) were assessed using correlation analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Baseline serum Fetuin-A, YKL-40, and hsCRP levels were significantly higher in patients with MetS compared to controls (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). During follow-up, changes in MetS severity were positively correlated with changes in hsCRP (r = 0.844,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), Fetuin-A (r = 0.918,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and YKL-40 (r = 0.913,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Sensitivity analysis using Kendall\u2019s tau-b confirmed robust monotonic associations (\u03c4 = 0.716\u20130.808, all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Fetuin-A and YKL-40 levels are strongly associated with both the presence and short-term changes in MetS severity. hsCRP appears to reflect longitudinal changes in metabolic burden. These findings suggest that selected inflammatory biomarkers may provide additional insight into the inflammatory and metabolic dynamics of MetS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15578518261443921","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:47:14Z","timestamp":1776426434000},"page":"311-317","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Can the Diagnosis of Metabolic Syndrome and the Severity of the Disease Be Determined with the Help of Inflammatory Biomarkers?"],"prefix":"10.1177","volume":"24","author":[{"given":"Hilal","family":"Bekta\u015f Uysal","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Ayd\u0131n Adnan Menderes University, Ayd\u0131n, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Bay\u011f\u0131n","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, S\u00f6ke State Hospital, Ayd\u0131n, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-1897","authenticated-orcid":false,"given":"Elif Duygu","family":"Topan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Ayd\u0131n Adnan Menderes University, Ayd\u0131n, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Y\u0131lmaz","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Ayd\u0131n Adnan Menderes University, Ayd\u0131n, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020786"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229776"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_888_23"},{"issue":"2","key":"e_1_3_2_5_1","article-title":"Association between baseline and changes in high-sensitive C-reactive protein and metabolic syndrome: A nationwide cohort study and meta-analysis","volume":"19","author":"Xue Q","year":"2022","unstructured":"4.Xue Q, , Yang X, , Huang Y, et al. Association between baseline and changes in high-sensitive C-reactive protein and metabolic syndrome: A nationwide cohort study and meta-analysis. Nutr Metab 2022;19(2).","journal-title":"Nutr Metab"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13092098"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26199682"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21605"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12113818"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112961"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20213079"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2024-0104"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00303-7"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13300"},{"key":"e_1_3_2_16_1","article-title":"Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome","volume":"16","author":"Akbo\u011fa MK","year":"2016","unstructured":"15.Akbo\u011fa MK, , Yal\u00e7\u0131n R, , \u015eahinarslan A, et al. Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome. Anatolian Journal of Cardiology\/Anadolu Kardiyoloji Dergisi 2016;16.","journal-title":"Anatolian Journal of Cardiology\/Anadolu Kardiyoloji Dergisi"},{"issue":"12","key":"e_1_3_2_17_1","first-page":"959","article-title":"YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease","volume":"16","author":"Schernthaner G-H","year":"2016","unstructured":"16.Schernthaner G-H, , H\u00f6baus C, , Brix J. YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease. Anatol J Cardiol 2016;16(12):959.","journal-title":"Anatol J Cardiol"}],"container-title":["Metabolic Syndrome and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15578518261443921","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15578518261443921","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15578518261443921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:36:28Z","timestamp":1785411388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15578518261443921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.1177\/15578518261443921"],"URL":"https:\/\/doi.org\/10.1177\/15578518261443921","relation":{},"ISSN":["1540-4196","1557-8518"],"issn-type":[{"value":"1540-4196","type":"print"},{"value":"1557-8518","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}